Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study: Most online pharmacies selling the chronic myeloid leukemia therapy imatinib are uncertified and could be operating unsafely.
To transfer Robin McGee’s information, her hospital system had to burn the data on a CD and send it snail mail. Bigger problems awaited.
People with left-sided tumors treated with Vectibix plus standard chemotherapy had an 18% lower risk of death.
While the risky procedure is not suitable for most people living with HIV, it offers clues for more feasible approaches.
Researchers are developing new treatments for people with HER2-positive breast cancer.
A combo treatment of Tafinlar and Mekinist may be better than chemo for some children with a brain cancer called low-grade glioma.
As they both deal with stage IV colon cancer, Kacie Peters and Erik Stanley are focused on living a normal, happy life with their son.
Azacitidine (Vidaza) was approved for pediatric patients with newly diagnosed juvenile myelomonocytic leukemia (JMML).
Helping young adult cancer survivors pay down their staggering medical bills and catch up to their peers in education and careers
An experimental drug saved his life and inspire him to connect others with cancer to bone marrow transplants and clinical trials.
A medical oncologist who has conducted over 100 clinical trials dedicated to reducing distressing symptoms of cancer and its treatments
A passion for improving cardiovascular health for people with cancer
How one doctor became a pioneer in quality of life research for people with cancer
Using mindfulness meditation and yoga to improve the lives of people with cancer
Women were at greater risk than men for symptomatic adverse events and hematologic events.
Results showed that women who had received anthracyclines and/or Herceptin had a high risk for heart failure.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.